Elixirr International PLC
10 July 2026
ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Director/PDMR Shareholding
Elixirr International plc (ELIX.L), an established, global award-winning challenger consultancy, announces the exercise of options over 100,000 ordinary shares in the share capital of the Company ("Ordinary Shares") by Nicholas Willott, CFO and Company Secretary, at an exercise price of 43.365p per share. These options were granted in May 2020.
This exercise has been satisfied from existing shares held in the Elixirr International plc Employee Benefit Trust and as a result there is no dilution in the equity of the Company. None of the shares resulting from the option exercise are being sold by Nicholas Willott other than 6,410 shares sold to cover the exercise price and stamp duty (based on the closing share price of £6.80 on 8 July 2026).
Following the exercise, Nicholas holds a total of 487,801 Ordinary Shares representing approximately 0.96% of the Company's issued share capital.
Enquiries:
For enquiries, please refer to the Company's Investor Contacts page:
https://www.elixirr.com/investors/investor-contacts
Elixirr International plc +44 (0)20 7220 5410
Stephen Newton, Chief Executive Officer
Graham Busby, Deputy Chief Executive Officer
Nicholas Willott, Chief Financial Officer and Company Secretary
investor-relations@elixirr.com
Cavendish Capital Markets Ltd (Broker) +44 (0)20 7220 0500
Stephen Keys, Callum Davidson, Isaac Hooper (Corporate Finance),
Sunila de Silva (ECM)
About Elixirr International plc
Elixirr is an award-winning global consulting firm working with clients across a diverse range of industries, markets and geographies. Founded in 2009, the firm set out to be the 'challenger consultancy' and do things differently than the large corporate consultancies dominating the industry: working openly and collaboratively with clients from start to finish, delivering outcomes based on innovative thinking, not methodology, and treating each client's business like their own. Elixirr was quoted on the AIM market of the London Stock Exchange in 2020 and listed on the Main Market of the London Stock Exchange in July 2025. In addition to strong organic growth, Elixirr has acquired nine boutique firms - Den Creative, Coast Digital, The Retearn Group, iOLAP, Responsum, Insigniam, Hypothesis, TRC Advisory, Kvadrant Consulting - to grow the Group's capabilities, diversify the business, expand into new geographies and access new clients.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Nicholas Willott |
||||
|
2. |
Reason for the Notification |
|||||
|
a) |
Position/status |
CFO and Company Secretary |
||||
|
b) |
Initial notification/Amendment |
Initial Notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Elixirr International plc |
||||
|
b) |
LEI |
213800MKY7OHMVAKW681 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary shares of 0.005p each ("Ordinary Shares") |
||||
|
Identification code |
GB00BLPHTX84 |
|||||
|
b) |
Nature of the transaction |
Exercise of options over Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information: · Aggregated volume · Price |
N/A - single transaction |
||||
|
e) |
Date of the transaction |
09 July 2026 |
||||
|
f) |
Place of the transaction |
Off market transaction |
||||
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
Name |
Nicholas Willott |
||||
|
2. |
Reason for the Notification |
|||||
|
a) |
Position/status |
CFO and Company Secretary |
||||
|
b) |
Initial notification/Amendment |
Initial Notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Elixirr International plc |
||||
|
b) |
LEI |
213800MKY7OHMVAKW681 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary shares of 0.005p each ("Ordinary Shares") |
||||
|
Identification code |
GB00BLPHTX84 |
|||||
|
b) |
Nature of the transaction |
Sale of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information: · Aggregated volume · Price |
N/A - single transaction |
||||
|
e) |
Date of the transaction |
09 July 2026 |
||||
|
f) |
Place of the transaction |
Off market transaction |
||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.